T A Connors. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Alkylating Agents/metabolismAlkylating Agents/therapeutic useAnimalsAntibiotics, Antineoplastic/therapeutic useAntimetabolites, Antineoplastic/therapeutic useAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBinding SitesCell Division/drug effectsCisplatin/therapeutic useDNA/metabolismDaunorubicin/pharmacologyDoxorubicin/pharmacologyHumansLeukemia L1210/drug therapyMiceMicrosomes, Liver/metabolismNeoplasms/drug therapyStructure-Activity Relationship
Substances: See more » Alkylating AgentsAntibiotics, AntineoplasticAntimetabolites, AntineoplasticAntineoplastic AgentsDoxorubicinDNACisplatinDaunorubicin
Year: 1975 PMID: 1102331 DOI: 10.1016/0014-5793(75)80305-x
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124